Reports from Bristol-Myers Squibb Company Describe Recent Advances in Schizophrenia (The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia)

Source :: Mental Health Weekly Digest. October 21, 2024, 109
Publication Year :: 2024
Abstract: 2024 OCT 21 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- New study results on schizophrenia have been published. According to news reporting originating [...]

Subjects :: Bristol-Myers Squibb Co. -- Reports
Medical research -- Reports
Medicine, Experimental -- Reports
Mental health -- Reports
Schizophrenia -- Care and treatment
Antipsychotic drugs -- Reports
Pharmaceutical industry -- Reports
Neurophysiology -- Reports
Health
Psychology and mental health

Tools